Papillary Thyroid Cancer Latest Advances

Journal: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...

Published: March 30, 2026

Histopathological evaluation of papillary thyroid carcinoma following thermal ablation.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: March 18, 2026

Papillary Thyroid Cancer Latest Advances

Find the Latest Research About Papillary Thyroid Cancer

Columnar Cell Subtype of Papillary Thyroid Carcinoma Is Characterized By A High Frequency of High-Grade Tumors That Exhibit Aggressive Clinicopathologic Features and Poor Outcomes: A Multicenter Study of 71 Cases.

Columnar Cell Subtype of Papillary Thyroid Carcinoma Is Characterized By A High Frequency of High-Grade Tumors That Exhibit Aggressive Clinicopathologic Features and Poor Outcomes: A Multicenter Study of 71 Cases.

Correction: Correction: Semaphorin 3D inhibits proliferation and migration of papillary thyroid carcinoma by regulating MAPK/ERK signaling pathway.

Correction: Correction: Semaphorin 3D inhibits proliferation and migration of papillary thyroid carcinoma by regulating MAPK/ERK signaling pathway.

Effect of 131iodine therapy on parathyroid function in postoperative patients with papillary thyroid carcinoma

Effect of 131iodine therapy on parathyroid function in postoperative patients with papillary thyroid carcinoma

A Temporal Analysis of Surgical Management and Outcomes Following ATA Guideline Updates in Papillary Thyroid Carcinoma: A Real-World Cohort Study of 31,861 Patients in South Korea.

A Temporal Analysis of Surgical Management and Outcomes Following ATA Guideline Updates in Papillary Thyroid Carcinoma: A Real-World Cohort Study of 31,861 Patients in South Korea.

Molecular and clinicopathological characteristics of NTRK fusions in papillary thyroid carcinoma: Hospital experience with a literature review.

Molecular and clinicopathological characteristics of NTRK fusions in papillary thyroid carcinoma: Hospital experience with a literature review.

Corrigendum to "STAT1-TCTN3 axis drives papillary thyroid carcinoma progression by accelerating the cell cycle and promoting tumor cell migration and invasion" [Int. J. Biol. Macromol. 344, Part 1 (2026) 150436].

Corrigendum to "STAT1-TCTN3 axis drives papillary thyroid carcinoma progression by accelerating the cell cycle and promoting tumor cell migration and invasion" [Int. J. Biol. Macromol. 344, Part 1 (2026) 150436].

miR-218 Overexpression Suppresses Tumorigenesis of Papillary Thyroid Cancer via Inactivation of PTEN /PI3K/AKT Pathway by Targeting Runx2 [Retraction].

miR-218 Overexpression Suppresses Tumorigenesis of Papillary Thyroid Cancer via Inactivation of PTEN /PI3K/AKT Pathway by Targeting Runx2 [Retraction].

Omitting Radioactive Iodine after Therapeutic Lateral Neck Dissection May Be the Next Step in De-Escalating Initial Treatment of Papillary Thyroid Cancer.

Omitting Radioactive Iodine after Therapeutic Lateral Neck Dissection May Be the Next Step in De-Escalating Initial Treatment of Papillary Thyroid Cancer.

EPR26-160: Demographic and Therapeutic Disparities in Survival Outcomes of Columnar Cell Papillary Thyroid Carcinoma: A SEER Database Analysis.

EPR26-160: Demographic and Therapeutic Disparities in Survival Outcomes of Columnar Cell Papillary Thyroid Carcinoma: A SEER Database Analysis.

Optimizing Post-Therapeutic Imaging in Papillary Thyroid Cancer: A Critical Comparison of Ultrasound and I-131 SPECT/CT.

Optimizing Post-Therapeutic Imaging in Papillary Thyroid Cancer: A Critical Comparison of Ultrasound and I-131 SPECT/CT.

FDG PET/CT imaging in recurrent papillary thyroid cancer: does BRAF mutation status matter?

FDG PET/CT imaging in recurrent papillary thyroid cancer: does BRAF mutation status matter?

Histopathological evaluation of papillary thyroid carcinoma following thermal ablation.

Histopathological evaluation of papillary thyroid carcinoma following thermal ablation.